Home › Myositis
Myositis clinical trials recruiting in the U.S.
20 studies for Myositis are recruiting participants at sites across the United States.
Myositis means inflammation of the muscles. Two specific types are polymyositis and dermatomyositis. Read about myositis symptoms and management.
Cities with the most studies
- Durham, NC10 studies
- Boston, MA6 studies
- New York City, NY6 studies
- Miami, FL5 studies
- Chicago, IL5 studies
- Houston, TX4 studies
- Los Angeles, CA4 studies
- Cedar Rapids, IA4 studies
- Baltimore, MD4 studies
- Pittsburgh, PA3 studies
- Plantation, FL3 studies
- Phoenix, AZ3 studies
- Jacksonville, FL3 studies
- Washington, DC3 studies
- Ann Arbor, MI3 studies
- Dallas, TX3 studies
- Charlotte, NC3 studies
By state
- Alabama3 studies
- Arizona4 studies
- California11 studies
- Florida8 studies
- Georgia3 studies
- Illinois6 studies
- Iowa4 studies
- Kansas3 studies
- Maryland7 studies
- Massachusetts6 studies
- Michigan3 studies
- Minnesota4 studies
- New York7 studies
- North Carolina12 studies
- Pennsylvania4 studies
- Tennessee3 studies
- Texas7 studies
Recently updated studies
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RecruitingPhase 2/3
Ages 6 to 75 · All sexes · Updated Nov 13, 2026 · NCT06154252Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07103746A Study of AZD0120 in Autoimmune Diseases
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Nov 10, 2026 · NCT07295847A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
Ages 18 to 74 · All sexes · Updated Nov 2, 2026 · NCT07085104A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Oct 30, 2026 · NCT06733935Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07823101A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Oct 26, 2026 · NCT06925542A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Oct 19, 2026 · NCT06916806Environmental Risk Factors for the Anti-synthetase Syndrome
RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 100 · All sexes · Updated Oct 16, 2026 · NCT01276470Adult and Juvenile Myositis
RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 100 · All sexes · Updated Sep 24, 2026 · NCT00017914A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT05895786FT839 in Autoimmune Diseases
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Sep 2, 2026 · NCT07800871Descartes-08 in Autoantibody Myositis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT07391605AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06991114A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Jul 14, 2026 · NCT07115745A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
RecruitingPhase 1
Ages 12 to 70 · All sexes · Updated May 22, 2026 · NCT06308978Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Apr 27, 2026 · NCT07160205Muscle Health Measurements Using Electrical Impedance Myography
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 89 · All sexes · Updated Apr 3, 2026 · NCT07502989MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
RecruitingObservational study
Ages 7 and older · All sexes · Updated Jan 28, 2026 · NCT07374107Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis
RecruitingEarly phase 1
Ages 45 to 75 · All sexes · Updated Jan 16, 2026 · NCT06479863From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.